SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-1.77%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$180M
AUM Growth
+$180M
(+2.2%)
Cap. Flow
+$8.72M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
37.35%
Holding
45
New
7
Increased
15
Reduced
13
Closed
4
Top Buys
| 1 |
Waters Corp
WAT
|
$4.04M |
| 2 |
Revvity
RVTY
|
$3.01M |
| 3 |
Baxter International
BAX
|
$2.96M |
| 4 |
HCA Healthcare
HCA
|
$2.76M |
| 5 |
Biogen
BIIB
|
$2.67M |
Top Sells
| 1 |
Sanofi
SNY
|
$3.75M |
| 2 |
Charles River Laboratories
CRL
|
$3.21M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
$3.12M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$3.07M |
| 5 |
Humana
HUM
|
$2.43M |
Sector Composition
| 1 | Healthcare | 99.5% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
HCA Healthcare
HCA
$94.8B
| $7.81M | 4.34% |
42,500
+15,000
| +55% | +$2.76M |
|
2
Thermo Fisher Scientific
TMO
$182B
| $7.61M | 4.23% |
15,000
+2,500
| +20% | +$1.27M |
|
3
Boston Scientific
BSX
$157B
| $7.17M | 3.98% |
185,000
| – | – |
|
4
Cigna
CI
$80.7B
| $6.94M | 3.86% |
25,000
| – | – |
|
|
5
Baxter International
BAX
$12.4B
| $6.46M | 3.59% |
120,000
+55,000
| +85% | +$2.96M |
|
6
Danaher
DHR
$144B
| $6.46M | 3.59% |
25,000
-1,000
| -4% | -$258K |
|
7
Zimmer Biomet
ZBH
$20.9B
| $6.27M | 3.49% |
60,000
+10,000
| +20% | +$1.05M |
|
8
Tenet Healthcare
THC
$16.3B
| $6.19M | 3.44% |
120,000
+50,000
| +71% | +$2.58M |
|
9
Stryker
SYK
$148B
| $6.18M | 3.43% |
30,500
| – | – |
|
10
Johnson & Johnson
JNJ
$428B
| $6.13M | 3.4% |
37,500
+12,500
| +50% | +$2.04M |
|
11
Agilent Technologies
A
$34.7B
| $6.08M | 3.38% |
50,000
+20,000
| +67% | +$2.43M |
|
12
UnitedHealth
UNH
$281B
| $6.06M | 3.37% |
12,000
-3,500
| -23% | -$1.77M |
|
13
McKesson
MCK
$86B
| $5.95M | 3.31% |
17,500
-5,000
| -22% | -$1.7M |
|
14
Universal Health Services
UHS
$11.5B
| $5.73M | 3.19% |
65,000
+17,500
| +37% | +$1.54M |
|
15
Eli Lilly
LLY
$653B
| $5.66M | 3.15% |
17,500
-4,002
| -19% | -$1.29M |
|
16
Intuitive Surgical
ISRG
$167B
| $5.62M | 3.13% |
30,000
+10,000
| +50% | +$1.87M |
|
17
Acadia Healthcare
ACHC
$2.13B
| $5.47M | 3.04% |
70,000
| – | – |
|
18
Cardinal Health
CAH
$35.7B
| $5.33M | 2.96% |
80,000
+40,000
| +100% | +$2.67M |
|
|
19
Humana
HUM
$37.6B
| $5.09M | 2.83% |
10,500
-5,000
| -32% | -$2.43M |
|
20
Elevance Health
ELV
$72.9B
| $5M | 2.78% |
11,000
-4,000
| -27% | -$1.82M |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.66M | 2.59% |
55,000
+7,500
| +16% | +$636K |
|
22
Cencora
COR
$57.3B
| $4.06M | 2.26% |
30,000
-10,000
| -25% | -$1.35M |
|
|
23
Waters Corp
WAT
$17.5B
| $4.04M | 2.25% |
+15,000
| New | +$4.04M |
|
24
Novo Nordisk
NVO
$248B
| $3.99M | 2.21% |
40,000
-20,000
| -33% | -$1.99M |
|
25
Centene
CNC
$14.5B
| $3.89M | 2.16% |
50,000
-25,000
| -33% | -$1.95M |
|